Target Evaluation and Validation Report
In the earliest phases of drug discovery it is critical that the evaluation of candidate targets is comprehensive and well understood. The goal is to identify the state-of-the-art research around a candidate target and the potential surrogate biomarkers.
Amplion provides an unmatched ability to comprehensively understand a candidate target and, more importantly, surrogate biomarkers that can determine the effectivity, patient populations and, safety potential for a candidate target.
Our solutions team is experienced in key target analysis and insight to ensure evidence-based go/no-go decisions in the earliest phases of a drug programs discovery and development.
We provide these solutions through detailed literature, trial, drug, and other evidence review for key biological information, especially pathway and MOA information.
Target Evaluation and Validation Report:
- Executive summary
- Project background
- Detailed literature and trial review
- Biomarker interaction (e.g. up regulated, down regulated)
- Gene expression study findings
- Detailed data from relevant studies
- Full Bibliography